GEHC
GE HealthCarePrevious close
76.57
Change
+0.15 / +0.20%
P/E (TTM) ?
17.4
Market Cap
$34.6B
1M
+17.13%
S&P 500 −0.91% over same period
Volume / Avg Volume
4.0M / 3.9M
1.02× average
Latest earnings analysisFY2026 Q2Reported 2026-07-23
GE HealthCare Q2 2026: EPS beat, orders up 11.1%, margin slips, guidance held
GE HealthCare beat on earnings but not on profitability: adjusted EPS of $1.13 topped the $1.0558 consensus while adjusted EBIT margin slipped to 14.2%. Orders grew 11.1% organically and full-year guidance was reaffirmed, yet Patient Care Solutions is still shrinking. The view is Neutral — a solid commercial quarter wrapped around a softer underlying margin story.
Read the full analysis →Revenue$5.29BYoY +5.80%
EPS (non-GAAP)$1.13Beatest. $1.06
Next-day move−2.27%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-23 | $5.3B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-29 | $5.1B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-04 | $20.6B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-29 | $5.1B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-30 | $5.0B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-30 | $4.8B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 41 of its 5-year rangeMid-range
5-year range 14.8 – 28.3 · Median 18.8
Last 4 quarters: $300M in buybacks + $64.0M in dividends, 1.05% of market cap combined
P/E (TTM)
17.4
P/B
3.2
P/S
1.6
Dividend Yield
0.16%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.0% on average on the first trading day after, rising 1 times
Most recent −2.27%
Volatility & Correlation
1-year beta 0.66 · Correlation with S&P 500 0.24Low beta
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 5.51 | +7.2% | — | 0.62 | 1.36 |
| FY2026 Q2 | 5.30 | +5.8% | — | 0.56 | 1.24 |
| FY2026 Q1 | 5.13 | +7.4% | — | 0.39 | 0.85 |
| FY2025 Q4 | 5.70 | +7.1% | — | 0.59 | 1.28 |
| FY2025 Q3 | 5.14 | +5.8% | — | 0.45 | 0.98 |
| FY2025 Q2 | 5.01 | +3.5% | — | 0.49 | 1.06 |
| FY2025 Q1 | 4.78 | +2.7% | — | 0.56 | 1.23 |
| FY2024 Q4 | 5.32 | +2.2% | — | 0.72 | 1.58 |
| FY2024 Q3 | 4.86 | +0.9% | — | 0.47 | 1.02 |
| FY2024 Q2 | 4.84 | +0.5% | — | 0.43 | 0.93 |
| FY2024 Q1 | 4.65 | −1.2% | — | 0.37 | 0.81 |
| FY2023 Q4 | 5.21 | +5.4% | — | 0.40 | 0.89 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| GEHC | 17.4 | +7.2% | — | +17.13% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |